-
Real-World Effectiveness of Atezolizumab-Bevacizumab, Lenvatinib and Sorafenib in the Patients With Unresectable Hepatocellular Carcinoma: A Multi-institutional Study in Taiwan
Sep 18, 2025, 18:38 PM -
Research on the Driving Mechanism of Corporate Participation in Governance for Health—An Empirical Analysis Based on Chinese Listed Companies
Sep 18, 2025, 18:38 PM -
Patient Voices in Health Technology Assessments: Insights From Australia and Singapore
Sep 18, 2025, 18:38 PM -
Exploring the Evaluation of Network Meta-Analysis Assumptions: Current Approaches and Practices
Sep 18, 2025, 18:38 PM -
Real-World Utilization, Persistence, and Effectiveness of Biologic Therapies in Patients With Severe Asthma: A Multicenter Retrospective Cohort Study in Taiwan
Sep 18, 2025, 18:38 PM -
Prescription Trends for ADHD Medications in Japan, 2018-2023
Sep 18, 2025, 18:38 PM -
Association Between Barriers to Accessing General Practitioners and Emergency Department Visits in New Zealand
Sep 18, 2025, 18:38 PM -
Integrating Real World Evidence in Economic Evaluation of Herpes Zoster Vaccination Among Kidney Transplant Patients in Thailand
Sep 18, 2025, 18:38 PM -
An EQ-5D Multilayered Measure of Health-Related Quality of Life: Is There Relevance and Need for It?
Sep 18, 2025, 18:38 PM -
Assessing Early Adoption of Pulsed Field Ablation for the Treatment of Atrial Fibrillation Using Claims and Hospital Charge Data
Sep 18, 2025, 18:38 PM -
Economic Evaluation of Selumetinib for Treating Pediatric Patients With Neurofibromatosis Type 1 Inoperable Plexiform Neurofibromas in Thailand
Sep 18, 2025, 18:38 PM -
Preferences and Willingness to Pay for Maintenance Inhalers Among Adults With Chronic Obstructive Pulmonary Disease in Thailand: A Discrete Choice Experiment
Sep 18, 2025, 18:38 PM -
Pharmaceutical Approaches to Enhancing RWE Data Collected in Non-Interventional Studies
Sep 18, 2025, 18:38 PM -
Cost-Effectiveness of Dostarlimab Plus Chemotherapy for Primary Advanced or Recurrent Endometrial Cancer From Taiwan’s National Health Insurance Perspective
Sep 18, 2025, 18:38 PM -
Using Real World Data to Estimate the Cost of Cardiac Implantable Electronic Device (CIED) Infection in a High-Risk Australian Population
Sep 18, 2025, 18:38 PM -
Characterising the Latency Period of Secondary Primary Malignancy and Lymphoma Onset Following Tisagenlecleucel (CAR-T Cell Therapy): A Real-World Data Analysis
Sep 18, 2025, 18:38 PM -
From Infection to Recovery: Health-Related Quality of Life Trajectories Among COVID-19 Patients in Selangor
Sep 18, 2025, 18:38 PM -
Burden of Intravenous Immunoglobulin Use Among Adults With Generalized Myasthenia Gravis in Japan
Sep 18, 2025, 18:38 PM -
Generating Real-World Utility Values for Pediatric Health States in Taiwan: A Nationwide EQ-5D-Y-3L Valuation Study Using Composite Time Trade-Off
Sep 18, 2025, 18:38 PM -
Characteristics and Accessibility of Orphan Drugs Through 2017-2024 National Drug Price Negotiation in China
Sep 18, 2025, 18:38 PM